Literature DB >> 26322868

Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery.

Shibing Tang1, Min Xie1, Nan Cao1, Sheng Ding1.   

Abstract

In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for generating ample supplies of cells to create unique platforms that model disease. This manuscript will review recent developments in modeling a variety of diseases (including their cellular phenotypes) with induced pluripotent stem cells derived from patients. It will also describe how researchers have exploited these models to validate drugs as potential therapeutics for these devastating diseases.

Entities:  

Mesh:

Year:  2015        PMID: 26322868     DOI: 10.1021/acs.jmedchem.5b00789

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

Review 1.  Stem Cell Spheroids and Ex Vivo Niche Modeling: Rationalization and Scaling-Up.

Authors:  Isotta Chimenti; Diana Massai; Umberto Morbiducci; Antonio Paolo Beltrami; Maurizio Pesce; Elisa Messina
Journal:  J Cardiovasc Transl Res       Date:  2017-03-13       Impact factor: 4.132

Review 2.  Human dermal fibroblasts in psychiatry research.

Authors:  S Kálmán; K A Garbett; Z Janka; K Mirnics
Journal:  Neuroscience       Date:  2016-02-09       Impact factor: 3.590

3.  Mitochondrial dysfunction in iPSC-derived neurons of subjects with chronic mountain sickness.

Authors:  Helen Zhao; Guy Perkins; Hang Yao; David Callacondo; Otto Appenzeller; Mark Ellisman; Albert R La Spada; Gabriel G Haddad
Journal:  J Appl Physiol (1985)       Date:  2017-12-21

Review 4.  Cell models for Down syndrome-Alzheimer's disease research.

Authors:  Yixing Wu; Nicole R West; Anita Bhattacharyya; Frances K Wiseman
Journal:  Neuronal Signal       Date:  2022-04-08

5.  Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy.

Authors:  Bin Xu; Alessandro Magli; Yoska Anugrah; Steven J Koester; Rita C R Perlingeiro; Wei Shen
Journal:  Biomaterials       Date:  2018-08-21       Impact factor: 12.479

6.  How to rekindle drug discovery process through integrative therapeutic targeting?

Authors:  Ashok Vaidya; Anuradha Roy; Rathnam Chaguturu
Journal:  Expert Opin Drug Discov       Date:  2018-08-27       Impact factor: 6.098

Review 7.  Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells.

Authors:  Dido Carrero; Clara Soria-Valles; Carlos López-Otín
Journal:  Dis Model Mech       Date:  2016-07-01       Impact factor: 5.758

Review 8.  Zebrafish small molecule screens: Taking the phenotypic plunge.

Authors:  Charles H Williams; Charles C Hong
Journal:  Comput Struct Biotechnol J       Date:  2016-09-18       Impact factor: 7.271

Review 9.  Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery.

Authors:  Masaki Hosoya; Katherine Czysz
Journal:  Cells       Date:  2016-12-21       Impact factor: 6.600

Review 10.  In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery.

Authors:  Kobra Zakikhan; Behshad Pournasr; Massoud Vosough; Marjan Nassiri-Asl
Journal:  Cell J       Date:  2017-02-22       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.